IL6 and depressive symptom measurement: Authors have suggested that high IL-6 plasmatic levels are associated with faster tumor progression, reduced response to chemotherapy and decreased survival [37], along with a direct relationship between high stress status, depression, and abnormal social behavior [53, 54].